Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site.... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Cardiff and Vale selects Nervecentre EPMA to enable clinical service transformation

Cardiff and Vale University Health Board (UHB) has signed a contract with Nervecentre to provide its electronic prescribing and medicines administration (EPMA) solution.
Cardiff and Vale selects Nervecentre EPMA
Published

Nervecentre’s cloud-based EPMA software will be deployed across nine hospitals in the region to help the health board achieve its strategy of using digital technology to enable clinical service transformation.

Cardiff and Vale UHB’s EPMA implementation will introduce a digital-first approach to medicines management that will revolutionise prescribing for nearly 7,000 clinicians and their patients. Nervecentre’s EPMA customers say that it gives them better visibility of medicine prescribing and administration, speeds up response times, and releases time for care.

Nervecentre was one of three companies awarded a place on the all-Wales EPMA framework in 2022. Cardiff and Vale UHB was the first health board to select its preferred EPMA system after running a rigorous and clinically-led competitive tender process. The Welsh Government has approved the health board’s business case.

Nervecentre’s modern cloud platform has the potential to enable collaboration and joined-up working with neighbouring health boards. The platform is also designed to enable rapid development and implementation of functional changes, supporting agile service transformation and zero planned downtime for updates.

Nervecentre’s strengths include class-leading usability and the availability of real-time data that can be captured and accessed on mobile devices to make hospitals safer and more efficient.

David Thomas, Director of Digital and Health Intelligence at Cardiff and Vale UHB said “Digital transformation is a priority for Cardiff and Vale UHB to shape the way we deliver services in the future and improve quality and patient care. We are looking forward to working with Nervecentre to implement and deliver the new EPMA system across our workforce, which will revolutionise the way we do things. The new system will be a positive culture change for the Health Board and increase patient safety. We will be working closely with staff groups over the coming months to build the system to meet our needs and provide training which will make a huge difference to the way we prescribe and administer medicines.”

Nervecentre CEO, Paul Volkaerts said: “I am very excited for Nervecentre to win its first contract in Wales and look forward to working closely with Cardiff and Vale UHB to digitise its prescribing. I am especially pleased to be working with an NHS organisation that is embracing the cloud technology we use daily in our personal lives, which will provide them with the agility and adaptability necessary for successful clinical service transformation at pace.”

This is a test bullet:

  • one
  • two
  • three

text after